Rouge Medical

Rouge Medical operates as a weight loss and hormone optimization clinic in Baton Rouge, LA, focusing on GLP-1 receptor agonist therapies for patients seeking medically supervised weight reduction. The clinic provides in-person consultations where providers assess metabolic health markers, body composition, and individual weight loss goals before initiating peptide-based treatment protocols. With a perfect 5.0-star rating across 17 Google reviews, Rouge Medical has established a reputation for accessible care in the Baton Rouge community, serving patients who require structured medical weight loss interventions beyond diet and exercise alone.

The clinic's primary therapeutic offerings center on two FDA-approved GLP-1 medications: Semaglutide and Tirzepatide. Semaglutide functions as a glucagon-like peptide-1 receptor agonist that regulates appetite and glucose metabolism, while Tirzepatide combines GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor activation for dual-pathway metabolic effects. Rouge Medical administers these peptides through weekly subcutaneous injections, with dosing protocols adjusted based on patient tolerance and weight loss progression. The clinic's approach integrates these medications with metabolic assessments to address underlying factors such as insulin resistance, hormonal imbalances affecting weight, and metabolic syndrome components that complicate traditional weight loss efforts.

Hormone optimization services at Rouge Medical complement the weight loss programs by addressing endocrine factors that influence metabolism, body composition, and weight regulation. Providers evaluate thyroid function, sex hormone levels, and cortisol patterns that may impede weight loss or contribute to metabolic dysfunction. This dual focus recognizes that sustainable weight reduction often requires correction of hormonal imbalances alongside caloric regulation. The Baton Rouge clinic conducts baseline laboratory testing to identify deficiencies or excesses that could undermine GLP-1 therapy effectiveness, creating individualized treatment plans that address both weight and hormonal health simultaneously.

Patients at Rouge Medical receive in-person care throughout their treatment journey, beginning with comprehensive intake appointments that include medical history review, current medication assessment, and discussion of weight loss expectations. Follow-up visits allow providers to monitor side effects common to GLP-1 therapies—such as nausea, gastrointestinal changes, or injection site reactions—and adjust dosing accordingly. The clinic's protocol includes regular weight checks, body composition analysis where applicable, and ongoing evaluation of metabolic markers to ensure patients progress safely toward their goals. This hands-on approach differs from telehealth-only models by providing direct provider interaction and immediate clinical assessment when concerns arise.

Rouge Medical serves the greater Baton Rouge area with a focus on making peptide-based weight loss accessible to Louisiana residents who qualify for these therapies based on BMI criteria and metabolic health status. The clinic's patient reviews reference insurance and payment considerations, indicating attention to financial accessibility within the medical weight loss space. By concentrating specifically on Semaglutide and Tirzepatide rather than offering an extensive menu of experimental peptides, Rouge Medical maintains a focused practice model centered on evidence-based GLP-1 therapies with established safety profiles and clinical outcomes data. This specialization allows the Baton Rouge team to develop deep expertise in managing these specific medications and the unique patient populations they serve.